Case number 1:18-cv-01789
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Cipla Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 12, 2023 | 18 | CONSENT JUDGMENT (CASE CLOSED) Signed by Judge Colm F. Connolly on 9/12/2023. Associated Cases: 1:18-cv-01788-CFC-SRF, 1:18-cv-01789-CFC-SRF, 1:19-cv-01494-CFC, 1:19-cv-01496-CFC(nmf) (Entered: 09/12/2023) (5) |
| Sep 6, 2023 | 17 | PROPOSED CONSENT JUDGMENT as to Defendants Cipla Limited, Cipla USA, Inc. and InvaGen Pharmaceuticals, Inc. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 09/06/2023) (5) |
| Mar 5, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Sherry R Fallon for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-01689-CFC-SRF et al.(cak) |
| Mar 5, 2019 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-01689-CFC-SRF. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE 18-1689-CFC ONLY. (nmf) |
| Mar 5, 2019 | 16 | Scheduling Order (21) Docket Text: SCHEDULING & CONSOLIDATION ORDER: These actions are consolidated for all purposes and all papers shall be filed in Lead Case No. 18-1689-CFC. Case referred to the Magistrate Judge for the purpose of exploring ADR. Case referred to the Magistrate Judge for all disputes relating to discovery matters and protective orders. Joinder of Parties due by 4/30/2020. Amended Pleadings due by 4/30/2020. Fact Discovery completed by 3/22/2020. Joint Claim Construction Brief due by 2/28/2020. A Markman Hearing is set for 4/7/2020 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Final Pretrial Conference is set for 4/8/2021 at 04:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 4/19/2021 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 3/4/2019. Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Mar 4, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 3/4/2019. (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Feb 28, 2019 | N/A | Set/Reset Hearings (0) Docket Text: Reset Hearings: The Scheduling Conference on 3/4/2019 at 02:30 PM before Judge Colm F. Connolly is rescheduled as a Telephonic Scheduling Conference per the letter and proposed scheduling order filed today stating that there are no areas of dispute. Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Feb 28, 2019 | 15 | Main Document (21) Docket Text: PROPOSED ORDER -- [Proposed] Scheduling Order -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Egan, Brian) |
| Feb 28, 2019 | 15 | Letter to The Honorable Colm F. Connolly (2) |
| Feb 1, 2019 | 14 | Answer to Counterclaim (10) Docket Text: ANSWER to [12] Answer to Complaint, Counterclaim by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Jan 11, 2019 | N/A | Add Corporate Affiliates/Parents (0) Docket Text: Corporate Affiliates/Parents added per Disclosure Statement: identifying Corporate Parent InvaGen Pharmaceuticals, Inc., Corporate Parent Cipla (EU) Limited for Cipla USA, Inc. (fms) |
| Jan 11, 2019 | 12 | Answer to Complaint (15) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Cipla USA, Inc., Cipla Limited.(Phillips, John) |
| Jan 11, 2019 | 13 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cipla Limited for Cipla USA, Inc. filed by Cipla Limited, Cipla USA, Inc.. (Phillips, John) |
| Jan 3, 2019 | 11 | Order Setting Scheduling Conference (9) Docket Text: Order Setting Scheduling Conference: A Scheduling Conference is set for 3/4/2019 at 02:30 PM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 1/3/2019. Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Dec 28, 2018 | 10 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Jack B. Blumenfeld regarding coordinated discovery and Markman proceedings, and to request a scheduling conference. (Blumenfeld, Jack) |
| Dec 17, 2018 | 9 | Order (8) Docket Text: ORDER, IT IS ORDERED that, on or before January 2, 2019, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 1/2/2019.) Signed by Judge Colm F. Connolly on 12/17/2018. Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Dec 11, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] STIPULATION TO EXTEND TIME to Answer or otherwise respond to the Complaint to January 11, 2019 filed by Cipla Limited, Cipla USA, Inc., Set/Reset Answer Deadlines: Cipla Limited answer due 1/11/2019; Cipla USA, Inc. answer due 1/11/2019. Signed by Judge Colm F. Connolly on 12/11/2018. (fms) |
| Dec 10, 2018 | 8 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Answer or otherwise respond to the Complaint to January 11, 2019 - filed by Cipla Limited, Cipla USA, Inc.. (Phillips, John) |
| Nov 27, 2018 | 6 | Declaration (9) Docket Text: DECLARATION of Mailing on Cipla Limited by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Blumenfeld, Jack) |
| Nov 27, 2018 | 7 | Declaration (9) Docket Text: DECLARATION of Mailing on Cipla USA, Inc. by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Blumenfeld, Jack) |
| Nov 14, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Cipla Limited on 11/14/2018; Cipla USA, Inc. on 11/14/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Nov 14, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:18-cv-01757-CFC, 1:18-cv-01758-CFC, 1:18-cv-01762-CFC through 1:18-cv-01765-CFC, 1:18-cv-01779-CFC, 1:18-cv-01783-CFC, and 1:18-cv-01785-CFC through 1:18-cv-01789-CFC (rjb) |
| Nov 13, 2018 | 1 | Main Document (10) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Cipla Limited, Cipla USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2502918.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation. (Attachments: # (1) Exhibit 1, # (2) Civil Cover Sheet)(nmg) |
| Nov 13, 2018 | 1 | Exhibit 1 (46) |
| Nov 13, 2018 | 1 | Civil Cover Sheet (1) |
| Nov 13, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Nov 13, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/2/2018. Date of Expiration of Patent: 6/11/2034.Thirty Month Stay Deadline: 2/1/2022. (nmg) |
| Nov 13, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,949,998 B2. (nmg) |
| Nov 13, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (nmg) |
| Nov 13, 2018 | 1 | Complaint* (1) |
